ScholarIQanswers from OpenAlex & ORCID
Lisa H. Butterfield
ResearcherPublications, citations & collaboration network
Lisa H. Butterfield is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Lisa H. Butterfield have?
ScholarIQindexed works
Lisa H. Butterfield has 499 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Lisa H. Butterfield have?
ScholarIQcitation count
Lisa H. Butterfield has 17,143 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Lisa H. Butterfield?
ScholarIQh-index
Lisa H. Butterfield has an h-index of 67 in OpenAlex.
What is the i10-index of Lisa H. Butterfield?
ScholarIQi10-index
Lisa H. Butterfield has an i10-index of 187 in OpenAlex.
What is the ORCID of Lisa H. Butterfield?
ScholarIQorcid
The ORCID for Lisa H. Butterfield is on the source record.
What is the OpenAlex record for Lisa H. Butterfield?
ScholarIQopenalex
The OpenAlex for Lisa H. Butterfield is on the source record.
What are the most-cited papers on Lisa H. Butterfield?
ScholarIQmost cited works
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
Hussein A. Tawbi, Melissa Burgess, Vanessa Bolejack, Brian A. Van Tine, Scott M. Schuetze, James Hu, Sandra P. D’Angelo, Steven Attia, Richard F. Riedel, Dennis A. Priebat, Sujana Movva, Lara E. Davis, Scott H. Okuno, Damon R. Reed, John Crowley, Lisa H. Butterfield, Ruth Salazar, Jaime Rodriguez‐Canales, Alexander J. Lazar, Ignacio I. Wistuba, Laurence H. Baker, Robert G. Maki, Denise K. Reinke, Shreyaskumar Patel
Induction of CD8<sup>+</sup>T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
Hideho Okada, Paweł Kaliński, Ryo Ueda, Aki Hoji, Gary Kohanbash, Teresa E. Donegan, Arlan Mintz, Johnathan A. Engh, David L. Bartlett, Charles K. Brown, Herbert J. Zeh, Matthew P. Holtzman, Todd A. Reinhart, Theresa L. Whiteside, Lisa H. Butterfield, Ronald L. Hamilton, Douglas M. Potter, Ian F. Pollack, Andres Μ. Salazar, Frank S. Lieberman
Defining the critical hurdles in cancer immunotherapy
Bernard A. Fox, Dolores J. Schendel, Lisa H. Butterfield, Steinar Aamdal, James P. Allison, Paolo A. Ascierto, Michael B. Atkins, Jiřina Bartůňková, Lothar Bergmann, Neil L. Berinstein, Cristina C Bonorino, Ernest C. Borden, Jonathan L. Bramson, Cedrik M. Britten, Xuetao Cao, William E. Carson, Alfred E. Chang, Dainius Characiejus, Aniruddha Choudhury, George Coukos, Tanja D. de Gruijl, Robert O. Dillman, Harry Dolstra, Glenn Dranoff, Lindy G. Durrant, James H. Finke, Jérôme Galon, Jared Gollob, Cécile Gouttefangeas, Fabio Grizzi, Michele Guida, Leif Håkansson, Kristen Hege, Ronald B. Herberman, F. Stephen Hodi, Axel Hoos, Christoph Huber, Patrick Hwu, Kohzoh Imai, Elizabeth M. Jaffee, Sylvia Janetzki, Carl H. June, Paweł Kaliński, Howard L. Kaufman, Koji Kawakami, Yutaka Kawakami, Ulrich Keilholtz, Samir N. Khleif, Rolf Kiessling, Beatrix Kotlán, Guido Kroemer, Réjean Lapointe, Hyam I. Levitsky, Michael T. Lotze, Cristina Maccalli, Michele Maio, Jens‐Peter Marschner, Michael J. Mastrangelo, Giuseppe Masucci, Ignacio Melero, C.J.M. Melief, William J. Murphy, Brad H. Nelson, Andrea Nicolini, Michael I. Nishimura, Kunle Odunsi, Pamela S. Ohashi, Jill O’Donnell-Tormey, Lloyd J. Old, Christian H. Ottensmeier, Michael Papamichail, Giorgio Parmiani, Graham Pawelec, Enrico Proietti, Shukui Qin, Robert C. Rees, Antoni Ribas, Ruggero Ridolfi, Gerd Ritter, Licia Rivoltini, Pedro Romero, Mohamed L. Salem, Rik J. Scheper, Barbara Seliger, Padmanee Sharma, Hiroshi Shiku, Harpreet Singh‐Jasuja, Wenru Song, Per thor Straten, Hideaki Tahara, Zhigang Tian, Sjoerd H. van der Burg, Paul von Hoegen, Ena Wang, Marij J.P. Welters, H. Winter, Tara Withington, Jedd D. Wolchok, Weihua Xiao, Laurence Zitvogel